Trademarkia Logo

Australia

AU$
RiboMab
Protected: Registered/protected

Last updated on 14 Apr 2022

Owner Info

BioNTech SE

An der Goldgrube 12

55131 Mainz, GERMANY

Serial Number

1881084 filed on 22 Aug 2017

Correspondent

metaCom LEGAL Nagel Markowsky Vossius Rechtsanwälte

Prinzregentenstr. 74,

81675 Munich,

GERMANY

RiboMab

Classification Information


Class [005]
Pharmaceuticals and veterinary preparations of all kinds, in particular for treating cancerous diseases, infections, autoimmune disorders and metaboli Read More

Class [040]
Treatment of materials and material conversion, namely custom manufacture of chemicals and biochemical substances; custom manufacture of chemicals and Read More

Class [042]
Scientific research for medical and veterinary purposes, in particular in respect of approaches for treating cancerous diseases, infections, autoimmun Read More

Class [044]
Medical and veterinary services in connection with the treatment of cancerous diseases, infections, autoimmune disorders and metabolic disorders

Mark Details


Serial Number

1881084

Registered On

22 Aug 2017

Renewal On

22 Aug 2027

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Mar 2017

Mark Type

EM

Legal History


Show more

Status DateAction Taken
14th Apr 2022Amendment to International Registration Contact Requested
6th Jan 2022Full Assignment - Subsequent Owner Registered Published
30th Dec 2021Full Assignment Requested
28th Jun 2018IP Right Registration Published
20th Jun 2018Application Status
20th Jun 2018Register Trade Mark
12th Apr 2018IP Right Acceptance Published
9th Apr 2018Application Accepted correspondence sent
9th Apr 2018Clear Examination report approved
9th Apr 2018User Created Notice correspondence sent